Leprosy and HIV coinfection: a critical approach

References

• Britton WJ, Lockwood DN. Leprosy. Lancet363(9416), 1209–1219 (2004).
   PubMed Web of Science ®Google Scholar
• Global leprosy situation, 2010. Wkly Epidemiol. Rec.85(35), 337–348 (2010).
   PubMedGoogle Scholar
• Naafs B. Leprosy and HIV: an analysis. Hansen Int.25(1), 63–66 (2000).
   Google Scholar
• Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect. Dis.6(6), 350–360 (2006).
   PubMed Web of Science ®Google Scholar
• Deps PD, Lockwood DN. Leprosy occurring as immune reconstitution syndrome. Trans. R. Soc. Trop. Med. Hyg.102(10), 966–968 (2008).
   PubMed Web of Science ®Google Scholar
• Naafs B. Some observations from the past year. Hansen Int.29, 51–56 (2004).
   Google Scholar
• Landay AL, Bettendorf D, Chan E et al. Evidence of immune reconstitution in anti-retroviral drug-experienced patients with advanced HIV disease. AIDS Res. Hum. Retroviruses18(2), 95–102 (2002).
   PubMed Web of Science ®Google Scholar
• Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin. Infect. Dis.36(1), e5–e6 (2003).
   Google Scholar
• Pignataro P, Rocha Ada S, Nery JA et al. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur. J. Clin. Microbiol. Infect. Dis.23(5), 408–411 (2004).
   PubMed Web of Science ®Google Scholar
• Visco-Comandini U, Longo B, Cuzzi T, Paglia MG, Antonucci G. Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome. Scand. J. Infect. Dis.36(11–12), 881–883 (2004).
   PubMed Web of Science ®Google Scholar
• Trindade MA, Manini MI, Masetti JH, Leite MA, Takashashi MD, Naafs B. Leprosy and HIV co-infection in five patients. Lepr. Rev.76(2), 162–166 (2005).
   PubMed Web of Science ®Google Scholar
• Kharkar V, Bhor UH, Mahajan S, Khopkar U. Type I lepra reaction presenting as immune reconstitution inflammatory syndrome. Indian J. Dermatol. Venereol. Leprol.73(4), 253–256 (2007).
   PubMed Web of Science ®Google Scholar
• Batista MD, Porro AM, Maeda SM et al. Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS. Clin. Infect. Dis.46, e56–e60 (2008).
   PubMed Web of Science ®Google Scholar
• Menezes VM, Sales AM, Illarramendi X et al. Leprosy reaction as a manifestation of immune reconstitution inflammatory syndrome: a case series of a Brazilian cohort. AIDS23(6), 641–643 (2009).
   PubMed Web of Science ®Google Scholar
• Couppié P, Abel S, Voinchet H et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch. Dermatol.140(8), 997–1000 (2004).
   PubMedGoogle Scholar
• Martiniuk F, Rao SD, Rea TH et al. Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons. Emerg. Infect. Dis.13(9), 1438–1440 (2007).
   PubMed Web of Science ®Google Scholar
• Trindade MA, Valente NY, Manini MI et al. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome. J. Clin. Microbiol.44(12), 4616–4618 (2006).
   PubMed Web of Science ®Google Scholar
• Talhari C, Mira MT, Massone C et al. Leprosy and HIV coinfection: a clinical, pathological, immunological, and therapeutic study of a cohort from a Brazilian referral center for infectious diseases. J. Infect. Dis.202(3), 345–354 (2010).
   PubMed Web of Science ®Google Scholar
• Couppié P, Domergue V, Clyti E et al. Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease. AIDS23(12), 1599–1600 (2009).
   PubMed Web of Science ®Google Scholar
• Vinay K, Smita J, Nikhil G, Neeta G. Human immunodeficiency virus and leprosy coinfection in Pune, India. J. Clin. Microbiol.47(9), 2998–2999 (2009).
   PubMed Web of Science ®Google Scholar
• Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis.34(3), 255–273 (1966).
   PubMedGoogle Scholar
• Nunzi E, Massone C. Leprosy: A Practical Guide in Global Health. Springer, Berlin, Germany (2011) (In Press).
   Google Scholar
• Walker SL, Lockwood DN. Leprosy type 1 (reversal) reactions and their management. Lepr. Rev.79(4), 372–386 (2008).
   PubMed Web of Science ®Google Scholar
• Van Veen NH, Lockwood DN, Van Brakel WH, Ramirez J Jr, Richardus JH. Interventions for erythema nodosum leprosum. A Cochrane review. Lepr. Rev.80(4), 355–372 (2009).
   PubMed Web of Science ®Google Scholar
• Lockwood DN, Sarno E, Smith WC. Classifying leprosy patients–searching for the perfect solution? Lepr. Rev.78(4), 317–320 (2007).
   PubMed Web of Science ®Google Scholar
• Deps P, Lockwood DN. Leprosy presenting as immune reconstitution inflammatory syndrome: proposed definitions and classification. Lepr. Rev.81(1), 59–68 (2010).
   PubMed Web of Science ®Google Scholar
• Massone C, Talhari C, Talhari S et al. Immunophenotype of skin lymphocytic infiltrate in M. leprae and HIV co-infected patients: a scenario dependent of CD8+ and/or CD20+ cells. Br. J. Dermatol. (2011) (In Press).
   Google Scholar
• Streeck H, Nixon DF. T cell immunity in acute HIV-1 infection. J. Infect. Dis.202(Suppl. 2), S302–S308 (2010).
   PubMedGoogle Scholar
• Massone C, Nunzi E, Ribeiro-Rodrigues R et al. T regulatory cells and plasmocytoid dendritic cells in Hansen disease: a new insight into pathogenesis? Am. J. Dermatopathol.32(3), 251–256 (2010).
   PubMed Web of Science ®Google Scholar
• Gulia A, Fried I, Massone C. New insights in the pathogenesis and genetics of leprosy. F1000 Med. Rep.2, 30 (2010).
   PubMedGoogle Scholar
• Nery JA, Sampaio EP, Galhardo MC et al. M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro. Indian J. Lepr.72(2), 155–167 (2000).
   PubMedGoogle Scholar
• Sampaio EP, Caneshi JR, Nery JA et al. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect. Immun.63(5), 1848–1854 (1995).
   PubMed Web of Science ®Google Scholar
• Naafs B, Chin-A-Lien RA, Tank B, van Joost T. Human immunodeficiency virus and leprosy. Trop. Geogr. Med.46(2), 119–122 (1994).
   PubMedGoogle Scholar
• Taflin C, Miyara M, Nochy D et al. FOXP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am. J. Pathol.174(2), 497–508 (2009).
   PubMed Web of Science ®Google Scholar
• Iyer AM, Mohanty KK, van Egmond D et al. Leprosy-specific B-cells within cellular infiltrates in active leprosy lesions. Hum. Pathol.38(7), 1065–1073 (2007).
   PubMed Web of Science ®Google Scholar
• Arora DR, Gautam V, Gill PS, Mishra N. Recent advances in antiretroviral therapy in HIV infection. J. Indian Med. Assoc.108(1), 29–34 (2010).
   PubMedGoogle Scholar
• Talhari C, Machado PR, Ferreira LC, Talhari S. Shifting of the clinical spectrum of leprosy in an HIV-positive patient: a manifestation of immune reconstitution inflammatory syndrome? Lepr. Rev.78(2), 151–154 (2007).
   PubMed Web of Science ®Google Scholar
• Talhari C, Ferreira LC, Araujo JR, Talhari AC, Talhari S. Immune reconstitution inflammatory syndrome or upgrading type 1 reaction? Report of two AIDS patients presenting a shifting from borderline lepromatous leprosy to borderline tuberculoid leprosy. Lepr. Rev.79(4), 429–435 (2008).
   PubMed Web of Science ®Google Scholar
• Sarno EN, Illarramendi X, Nery JA et al. HIV-M. leprae interaction: can HAART modify the course of leprosy? Public Health Rep.123(2), 206–212 (2008).
   PubMed Web of Science ®Google Scholar
• Whalen C, Horsburgh CR, Hom D et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med.151(1), 129–135 (1995).
   PubMed Web of Science ®Google Scholar
• Whalen CC, Nsubuga P, Okwera A et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS14(9), 1219–1228 (2000).
   PubMed Web of Science ®Google Scholar
• Pereira GA, Stefani MM, Araujo Filho JA, Souza LC, Stefani GP, Martelli CM. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am. J. Trop. Med. Hyg.71(5), 679–684 (2004).
   PubMed Web of Science ®Google Scholar
• de Almeida AM, Roselino AM, Foss NT. Leprosy and HIV infection. Int. J. Lepr. Other Mycobact. Dis.62(1), 133–135 (1994).
   PubMedGoogle Scholar
• Moran CA, Nelson AM, Tuur SM, Luengu M, Fonseca L, Meyers WM. Leprosy in five human immunodeficiency virus-infected patients. Mod. Pathol.8(6), 662–664 (1995).
   PubMed Web of Science ®Google Scholar
• Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M; IeDEA Southern and Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect. Dis.10(4), 251–261 (2010).
   PubMed Web of Science ®Google Scholar
• Opromolla DVA, Tonello CJS, Fleury RN. Borderline leprosy and HIV infection. Hansen Int.25, 54–59 (2000).
   Google Scholar
• Abels S, Helenon R, Ray V, Sobesky G, Cubie A. Tuberculoid leprosy neuritis following initiation of combination antiretroviral therapy. Presented at: 13th International AIDS Conference. Durban, South Africa, 9–14 July 2000.
   Google Scholar
• Pignataro PE, Nery JAC, Miranda A et al. Leprosy and AIDS: report of two cases in the beginning of HAART and inflammatory reactions. Presented at: 16th International Congress of Leprosy. Salvador, Brazil, 4–9 August 2002.
   Google Scholar
• Pavie J, De Castro N, Molina JM, Flageul B. Severe peripheral neuropathy following HAART initiation in an HIV-infected patient with leprosy. J. Int. Assoc. Physicians AIDS Care (Chic. Ill.)9(4), 232–235 (2010).
   PubMedGoogle Scholar
• Naafs B. Treatment of leprosy: science or politics? Trop. Med. Int. Health11(3), 268–278 (2006).
   PubMed Web of Science ®Google Scholar
• Worobec SM. Treatment of leprosy/Hansen’s disease in the early 21st Century. Dermatol. Ther.22(6), 518–537 (2009).
   PubMed Web of Science ®Google Scholar
• Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV. Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis.179(1), 187–191 (1999).
   PubMed Web of Science ®Google Scholar
• Meisner SJ, Mucklow S, Warner G, Sow SO, Lienhardt C, Hill AV. Association of NRAMP1 polymorphism with leprosy type but not susceptibility to leprosy per se in West Africans. Am. J. Trop. Med. Hyg.65(6), 733–735 (2001).
   PubMed Web of Science ®Google Scholar
• Rajalingam R, Singal DP, Mehra NK. Transporter associated with antigen-processing (TAP) genes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis. Tissue Antigens49(2), 168–172 (1997).
   PubMedGoogle Scholar
• Moraes MO, Pacheco AG, Schonkeren JJ et al. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun.5(7), 592–595 (2004).
   PubMed Web of Science ®Google Scholar
• Vanderborght PR, Pacheco AG, Moraes ME et al. HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun.8(4), 320–324 (2007).
   PubMed Web of Science ®Google Scholar
• Mira MT, Alcaïs A, Nguyen VT et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature427(6975), 636–640 (2004).
   PubMed Web of Science ®Google Scholar
• Alcais A, Alter A, Antoni G et al. Stepwise replication identifies a low-producing lymphotoxin-α allele as a major risk factor for early-onset leprosy. Nat. Genet.39(4), 517–522 (2007).
   PubMed Web of Science ®Google Scholar
• Moraes MO, Duppre NC, Suffys PN et al. Tumor necrosis factor-α promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients. Immunogenetics.53(1), 45–47 (2001).
   PubMed Web of Science ®Google Scholar
• Alter A, de Léséleuc L, Van Thuc N et al. Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum. Genet.127(3), 337–348 (2010).
   PubMed Web of Science ®Google Scholar
• Alter A, Grant A, Abel L, Alcaïs A, Schurr E. Leprosy as a genetic disease. Mamm. Genome.22(1–2), 19–31 (2010).
   PubMed Web of Science ®Google Scholar
• Wong SH, Hill AV, Vannberg FO et al. Genomewide association study of leprosy. N. Engl. J. Med.362(15), 1446–1447 (2010).
   PubMed Web of Science ®Google Scholar
• An P, Winkler CA. Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet.26(3), 119–131 (2010).
   PubMed Web of Science ®Google Scholar
• Malhotra D, Darvishi K, Sood S et al. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum. Genet.118(2), 295–300 (2005).
   PubMed Web of Science ®Google Scholar
• Shin HD, Winkler C, Stephens JC et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl Acad. Sci. USA97(26), 14467–14472 (2000).
   PubMed Web of Science ®Google Scholar
• Cobat A, Gallant CJ, Simkin L et al. Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. J. Exp. Med.206(12), 2583–2591 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang FR, Huang W, Chen SM et al. Genomewide association study of leprosy. N. Engl. J. Med.361(27), 2609–2618 (2009).
   PubMed Web of Science ®Google Scholar
• Sopoh GE, Dossou AD, Brun LV et al. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms. Am. J. Trop. Med. Hyg.83(2), 307–313 (2010).
   PubMedGoogle Scholar
• Kibadi K, Colebunders R, Muyembe-Tamfum JJ, Meyers WM, Portaels F. Buruli ulcer lesions in HIV-positive patient. Emerg. Infect. Dis.16(4), 738–739 (2010).
   PubMed Web of Science ®Google Scholar
• Johnson RC, Nackers F, Glynn JR et al. Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS22(7), 901–903 (2008).
   PubMed Web of Science ®Google Scholar
• Silva MT, Portaels F, Pedrosa J. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect. Dis.9(11), 699–710 (2010).
   Web of Science ®Google Scholar